Top Markets
#1 0G 0G +42.53%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.68%
#3 Useless Coin Useless Coin +35.88%
#4 SAFEcoin SAFEcoin +30.67%
#5 StonkBroker StonkBroker +27.91%
#6 Arbitrum Arbitrum +27.10%
#7 Notcoin Notcoin +19.19%
#8 Full Moon Full Moon +18.20%
#9 Zora Zora +16.97%
#10 Curve DAO Curve DAO +16.15%
Coin of the day
0G 0G
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Hisse Senetlerindeki Sıralama #13821
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Hisse Fiyatı
$12.63
Piyasa Değeri
$458.19M
Değişim (1 gün)
-3.26%
Değişim (1 yıl)
-
Ülke
US
Ticaret Evommune, Inc. (EVMN)

Kategori

Healthcare
Evommune, Inc. (EVMN) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $13.94 - 2026-08-01

Gün sonu en düşük fiyat: $19.25 - 2025-11-01
Evommune, Inc. için hisse fiyatı geçmişi: 2025 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 9.44%
2025 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.87%
CH